Showing results (21-30 of 66) with videos related to

Sort By:
Pageof 7
Anticancer Research|February 9, 2013
Feasibility trial for daily oral administration of the hypoxic sensitizer AK-2123 (Sanazole) in radiotherapyHideya Yamazaki, Satoaki Nakamura, Kana Kobayashi, et al.
Cureus|June 14, 2024
The Feasibility of Omission of Postoperative Radiotherapy in Japanese Patients With Early Breast Cancer Treated With Breast-Conserving SurgeryAkihiro Nakashima, Hideya Yamazaki, Gen Suzuki, et al.
Cancer Diagnosis & Prognosis|November 7, 2022
Palliative Radiation Therapy for Intramedullary Spinal Cord MetastasisTakeshi Nishimura, Hideya Yamazaki, Gen Suzuki, et al.
Anticancer Research|December 16, 2014
Analysis of intrafractional organ motion by megavoltage computed tomography in patients with lung cancer treated with image-guided stereotactic body radiotherapy using helical tomotherapyNorihiro Aibe, Hideya Yamazaki, Takuya Nishimura, et al.
Scientific Reports|October 26, 2023
Increasing rectum-prostate distance using a hydrogel spacer to reduce radiation exposure during proton beam therapy for prostate cancerTsukasa Narukawa, Norihiro Aibe, Masashi Tsujimoto, et al.
Cancers|May 14, 2022
Optimal Clinical Target Volume of Radiotherapy Based on Microscopic Extension around the Primary Gross Tumor in Non-Small-Cell Lung Cancer: A Systematic ReviewYukihisa Tamaki, Norihiro Aibe, Takafumi Komiyama, et al.
Case Reports in Oncology|June 4, 2026
Radiotherapy Targeting the Causative Lesion of Horner's Syndrome in Metastatic Breast Cancer: A Case Report and Literature ReviewGen Suzuki, Koji Masui, Satoshi Ikeda, et al.
Scientific Reports|February 7, 2024
Re-irradiation for isolated neck recurrence in head and neck tumor: impact of rN categoryHideya Yamazaki, Gen Suzuki, Norihiro Aibe, et al.
Cancers|December 24, 2021
Reirradiation for Nasal Cavity or Paranasal Sinus Tumor-A Multi-Institutional StudyHideya Yamazaki, Gen Suzuki, Norihiro Aibe, et al.
Anticancer Research|April 9, 2013
Hypofractionated stereotactic radiotherapy with the hypoxic sensitizer AK-2123 (sanazole) for reirradiation of brain metastases: a preliminary feasibility reportHideya Yamazaki, Satoaki Nakamura, Takuya Nishimura, et al.
Pageof 7